P.A. Beranek

1.2k total citations
31 papers, 975 citations indexed

About

P.A. Beranek is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, P.A. Beranek has authored 31 papers receiving a total of 975 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Genetics, 8 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in P.A. Beranek's work include Estrogen and related hormone effects (17 papers), Hormonal Regulation and Hypertension (6 papers) and Enzyme function and inhibition (5 papers). P.A. Beranek is often cited by papers focused on Estrogen and related hormone effects (17 papers), Hormonal Regulation and Hypertension (6 papers) and Enzyme function and inhibition (5 papers). P.A. Beranek collaborates with scholars based in United Kingdom, United States and Germany. P.A. Beranek's co-authors include V.H.T. James, Michael Reed, M.W. Ghilchik, Rosemary C. Bonney, Kathryn Davidson, R. C. Bonney, David Mutimer, David J. Brown, Keith Rolles and P McMaster and has published in prestigious journals such as The Lancet, Annals of the New York Academy of Sciences and British Journal of Cancer.

In The Last Decade

P.A. Beranek

30 papers receiving 927 citations

Peers

P.A. Beranek

GENET

EPIDE

HEPAT

EDM

Keigo Kawashima Japan

H. Skelly United States

Munawar Iqbal United Kingdom

Ma’an Amad Canada

S Mishkin Canada

N. D’Alessandro Italy

Pamela A. Marino United States

James P. Mapes United States

Bruce Dickstein United States

K. E. Paschkis United States

Keigo Kawashima Japan

P.A. Beranek

86 ×0.2

GENET

242 ×0.8

EPIDE

131 ×0.4

HEPAT

194 ×0.7

102 ×0.5

EDM

Citations per year, relative to P.A. Beranek P.A. Beranek (= 1×) peers Keigo Kawashima

Countries citing papers authored by P.A. Beranek

Since Specialization

Citations

This map shows the geographic impact of P.A. Beranek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.A. Beranek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.A. Beranek more than expected).

Fields of papers citing papers by P.A. Beranek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.A. Beranek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.A. Beranek. The network helps show where P.A. Beranek may publish in the future.

Co-authorship network of co-authors of P.A. Beranek

This figure shows the co-authorship network connecting the top 25 collaborators of P.A. Beranek. A scholar is included among the top collaborators of P.A. Beranek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.A. Beranek. P.A. Beranek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Beranek, P.A., et al.. (2018). [Non-Hodgkin´s B-lymphoma of the ovaries with an unfavourable prognosis - incidental finding during caesarean section].. PubMed. 83(1). 45–49. 1 indexed citations

Paz‐Ares, Luis, Robert L. Kunka, J Cassidy, et al.. (1998). A phase I clinical and pharmacokinetic study of the new topoisomerase inhibitor GI147211 given as a 72-h continuous infusion. British Journal of Cancer. 78(10). 1329–1336. 20 indexed citations

Grellier, Leonie, David Mutimer, Mèlika Ben Ahmed, et al.. (1996). Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. The Lancet. 348(9036). 1212–1215. 317 indexed citations

Mutimer, David, Mèlika Ben Ahmed, David J. Brown, et al.. (1996). Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. European Journal of Gastroenterology & Hepatology. 8(12). 1244–1244. 6 indexed citations

O’Dwyer, Peter J., Robert L. Kunka, J Cassidy, et al.. (1995). 928 Phase I trial of the topoisomerase I inhibitor GG211 as a 72-hour infusion. European Journal of Cancer. 31. S193–S193. 2 indexed citations

Bunce, K T, Michael B. Tyers, & P.A. Beranek. (1991). Clinical evaluation of 5-HT3 receptor antagonists as anti-emetics. Trends in Pharmacological Sciences. 12(2). 46–48. 34 indexed citations

Reed, Michael, et al.. (1988). A Direct Assay for Oestrone Sulphate and Its Use to Investigate the Effect of Ampicillin on Plasma Levels of Oestrone Sulphate. Hormone and Metabolic Research. 20(11). 713–716. 2 indexed citations

Reed, Michael, P.A. Beranek, R.W. Cheng, Judith McNeill, & V.H.T. James. (1987). Peripheral oestrogen metabolism in postmenopausal women with or without breast cancer: The role of dietary lipids and growth factors. Journal of Steroid Biochemistry. 27(4-6). 985–989. 1 indexed citations

Reed, Michael, P.A. Beranek, M.W. Ghilchik, & V.H.T. James. (1986). Estrogen production and metabolism in normal postmenopausal women and postmenopausal women with breast or endometrial cancer. European Journal of Cancer and Clinical Oncology. 22(11). 1395–1400. 22 indexed citations

10.

Reed, Michael, P.A. Beranek, & V.H.T. James. (1986). Oestrogen production and metabolism in peri-menopausal women. Maturitas. 8(1). 29–34. 2 indexed citations

11.

James, V.H.T., Michael Reed, P.A. Beranek, et al.. (1986). Androgen and Estrogen Metabolism in Breast Cancer Patients^a. Annals of the New York Academy of Sciences. 464(1). 117–125. 2 indexed citations

12.

Bonney, R. C., Michael Reed, P.A. Beranek, M.W. Ghilchik, & V.H.T. James. (1986). Metabolism of [3H]oestradiol in vivo by normal breast and tumour tissue in postmenopausal women. Journal of Steroid Biochemistry. 24(1). 361–364. 21 indexed citations

13.

Reed, Michael, P.A. Beranek, S. Franks, & V.H.T. James. (1986). The Effect of Glucocorticoids on theIn VivoConversion of Androstenedione to Oestrone. Hormone and Metabolic Research. 18(9). 635–637. 20 indexed citations

14.

Reed, Martin, P.A. Beranek, M.W. Ghilchik, & V.H.T. James. (1985). Conversion of estrone to estradiol and estradiol to estrone in postmenopausal women.. PubMed. 66(3). 361–5. 11 indexed citations

15.

Reed, Michael, P.A. Beranek, R.W. Cheng, M.W. Ghilchik, & V.H.T. James. (1985). The distribution of oestradiol in plasma from postmenopausal women with or without breast cancer: Relationships with metabolic clearance rates of oestradiol. International Journal of Cancer. 35(4). 457–460. 17 indexed citations

16.

Bonney, R. C., Michael Reed, P.A. Beranek, & V.H.T. James. (1985). Metabolism of adrenal androgens by human endometrium and adrenal cortex. Journal of Steroid Biochemistry. 23(3). 347–352. 11 indexed citations

17.

Bonney, Rosemary C., et al.. (1984). The interrelationship between plasma 5-ene adrenal androgens in normal women. Journal of Steroid Biochemistry. 20(6). 1353–1355. 28 indexed citations

18.

Bonney, Rosemary C., et al.. (1984). Adrenal androgen concentrations in breast tumours and in normal breast tissue. The relationship to oestradiol metabolism. Journal of Steroid Biochemistry. 20(1). 501–504. 32 indexed citations

19.

James, V.H.T., Elizabeth Folkerd, R. C. Bonney, P.A. Beranek, & Michael Reed. (1982). Factors influencing estrogen production and metabolism in postmenopausal women with endocrine cancer. Journal of Endocrinological Investigation. 5(5). 335–345. 10 indexed citations

20.

Beranek, P.A., et al.. (1972). Die Diagnosesicherung (C-Schl�ssel), eine notwendige Erg�nzung der TNM-Klassifizierung beim Brustkrebs. Journal of Cancer Research and Clinical Oncology. 77(4). 262–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact